The anesthetic efficacy of 4 percent articaine 1:200,000 epinephrine: Two controlled clinical trials

Paul A. Moore, Sean C. Boynes, Elliot V. Hersh, Scott S. DeRossi, Thomas P. Sollecito, J. Max Goodson, Juliana S. Leonel, Constantinos Floros, Carrie Peterson, Matthew Hutcheson

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Objective. The authors conducted two double-blinded, randomized, multicenter clinical trials to determine the efficacy and clinical anesthetic characteristics of 4 percent articaine hydrochloride (HCl) with 1:200,000 epinephrine (A200) as compared with those of 4 percent articaine HCl with 1:100,060 epinephrine (A100) and 4 percent articaine HCl without epinephrine (Aw/o). Methods. During separate testing sessions, members of the authors' research team used three articaine study formulations to induce either inferior alveolar nerve block anesthesia (Trial 1) or maxillary infiltration anesthesia (Trial 2). In each trial, subjects received, in a randomized sequence, each of the three formulations to determine efficacy (success rate) and anesthetic characteristics (onset time and duration). The authors evaluated pulpal anesthesia via subjects' response to electric pulp testing (EPT). Results. A total of 126 subjects were enrolled in the two studies (63 subjects in each trial). In both mandibular and maxillary trials, the success rates for inducing profound anesthesia (EPT score ≥ 80), the mean onset times and the mean durations of anesthesia were similar for both epinephrine-containing formulations (A200 and A100). In subjects who received the formulation containing no epinephrine (Aw/o), the success rate for profound anesthesia was significantly less. Conclusion. These studies demonstrated that the inclusion of epinephrine in 4 percent articaine anesthetic formulations is essential for achieving profound anesthesia. The authors found that the A200 formulation provided a level of pulpal anesthesia comparable with that of the A100 formulation.

Original languageEnglish (US)
Pages (from-to)1572-1581
Number of pages10
JournalJournal of the American Dental Association
Volume137
Issue number11
DOIs
StatePublished - Jan 1 2006

Fingerprint

Carticaine
Controlled Clinical Trials
Epinephrine
Anesthetics
Anesthesia
Electronarcosis
Mandibular Nerve
Nerve Block
Local Anesthesia
Multicenter Studies
Randomized Controlled Trials
Research

Keywords

  • Articaine
  • Clinical trial
  • Dentistry
  • Epinephrine
  • Local anesthesia

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Moore, P. A., Boynes, S. C., Hersh, E. V., DeRossi, S. S., Sollecito, T. P., Goodson, J. M., ... Hutcheson, M. (2006). The anesthetic efficacy of 4 percent articaine 1:200,000 epinephrine: Two controlled clinical trials. Journal of the American Dental Association, 137(11), 1572-1581. https://doi.org/10.14219/jada.archive.2006.0093

The anesthetic efficacy of 4 percent articaine 1:200,000 epinephrine : Two controlled clinical trials. / Moore, Paul A.; Boynes, Sean C.; Hersh, Elliot V.; DeRossi, Scott S.; Sollecito, Thomas P.; Goodson, J. Max; Leonel, Juliana S.; Floros, Constantinos; Peterson, Carrie; Hutcheson, Matthew.

In: Journal of the American Dental Association, Vol. 137, No. 11, 01.01.2006, p. 1572-1581.

Research output: Contribution to journalArticle

Moore, PA, Boynes, SC, Hersh, EV, DeRossi, SS, Sollecito, TP, Goodson, JM, Leonel, JS, Floros, C, Peterson, C & Hutcheson, M 2006, 'The anesthetic efficacy of 4 percent articaine 1:200,000 epinephrine: Two controlled clinical trials', Journal of the American Dental Association, vol. 137, no. 11, pp. 1572-1581. https://doi.org/10.14219/jada.archive.2006.0093
Moore, Paul A. ; Boynes, Sean C. ; Hersh, Elliot V. ; DeRossi, Scott S. ; Sollecito, Thomas P. ; Goodson, J. Max ; Leonel, Juliana S. ; Floros, Constantinos ; Peterson, Carrie ; Hutcheson, Matthew. / The anesthetic efficacy of 4 percent articaine 1:200,000 epinephrine : Two controlled clinical trials. In: Journal of the American Dental Association. 2006 ; Vol. 137, No. 11. pp. 1572-1581.
@article{81712d6503ea4e75a89390eee2370b14,
title = "The anesthetic efficacy of 4 percent articaine 1:200,000 epinephrine: Two controlled clinical trials",
abstract = "Objective. The authors conducted two double-blinded, randomized, multicenter clinical trials to determine the efficacy and clinical anesthetic characteristics of 4 percent articaine hydrochloride (HCl) with 1:200,000 epinephrine (A200) as compared with those of 4 percent articaine HCl with 1:100,060 epinephrine (A100) and 4 percent articaine HCl without epinephrine (Aw/o). Methods. During separate testing sessions, members of the authors' research team used three articaine study formulations to induce either inferior alveolar nerve block anesthesia (Trial 1) or maxillary infiltration anesthesia (Trial 2). In each trial, subjects received, in a randomized sequence, each of the three formulations to determine efficacy (success rate) and anesthetic characteristics (onset time and duration). The authors evaluated pulpal anesthesia via subjects' response to electric pulp testing (EPT). Results. A total of 126 subjects were enrolled in the two studies (63 subjects in each trial). In both mandibular and maxillary trials, the success rates for inducing profound anesthesia (EPT score ≥ 80), the mean onset times and the mean durations of anesthesia were similar for both epinephrine-containing formulations (A200 and A100). In subjects who received the formulation containing no epinephrine (Aw/o), the success rate for profound anesthesia was significantly less. Conclusion. These studies demonstrated that the inclusion of epinephrine in 4 percent articaine anesthetic formulations is essential for achieving profound anesthesia. The authors found that the A200 formulation provided a level of pulpal anesthesia comparable with that of the A100 formulation.",
keywords = "Articaine, Clinical trial, Dentistry, Epinephrine, Local anesthesia",
author = "Moore, {Paul A.} and Boynes, {Sean C.} and Hersh, {Elliot V.} and DeRossi, {Scott S.} and Sollecito, {Thomas P.} and Goodson, {J. Max} and Leonel, {Juliana S.} and Constantinos Floros and Carrie Peterson and Matthew Hutcheson",
year = "2006",
month = "1",
day = "1",
doi = "10.14219/jada.archive.2006.0093",
language = "English (US)",
volume = "137",
pages = "1572--1581",
journal = "Journal of the American Dental Association",
issn = "0002-8177",
publisher = "American Dental Association",
number = "11",

}

TY - JOUR

T1 - The anesthetic efficacy of 4 percent articaine 1:200,000 epinephrine

T2 - Two controlled clinical trials

AU - Moore, Paul A.

AU - Boynes, Sean C.

AU - Hersh, Elliot V.

AU - DeRossi, Scott S.

AU - Sollecito, Thomas P.

AU - Goodson, J. Max

AU - Leonel, Juliana S.

AU - Floros, Constantinos

AU - Peterson, Carrie

AU - Hutcheson, Matthew

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Objective. The authors conducted two double-blinded, randomized, multicenter clinical trials to determine the efficacy and clinical anesthetic characteristics of 4 percent articaine hydrochloride (HCl) with 1:200,000 epinephrine (A200) as compared with those of 4 percent articaine HCl with 1:100,060 epinephrine (A100) and 4 percent articaine HCl without epinephrine (Aw/o). Methods. During separate testing sessions, members of the authors' research team used three articaine study formulations to induce either inferior alveolar nerve block anesthesia (Trial 1) or maxillary infiltration anesthesia (Trial 2). In each trial, subjects received, in a randomized sequence, each of the three formulations to determine efficacy (success rate) and anesthetic characteristics (onset time and duration). The authors evaluated pulpal anesthesia via subjects' response to electric pulp testing (EPT). Results. A total of 126 subjects were enrolled in the two studies (63 subjects in each trial). In both mandibular and maxillary trials, the success rates for inducing profound anesthesia (EPT score ≥ 80), the mean onset times and the mean durations of anesthesia were similar for both epinephrine-containing formulations (A200 and A100). In subjects who received the formulation containing no epinephrine (Aw/o), the success rate for profound anesthesia was significantly less. Conclusion. These studies demonstrated that the inclusion of epinephrine in 4 percent articaine anesthetic formulations is essential for achieving profound anesthesia. The authors found that the A200 formulation provided a level of pulpal anesthesia comparable with that of the A100 formulation.

AB - Objective. The authors conducted two double-blinded, randomized, multicenter clinical trials to determine the efficacy and clinical anesthetic characteristics of 4 percent articaine hydrochloride (HCl) with 1:200,000 epinephrine (A200) as compared with those of 4 percent articaine HCl with 1:100,060 epinephrine (A100) and 4 percent articaine HCl without epinephrine (Aw/o). Methods. During separate testing sessions, members of the authors' research team used three articaine study formulations to induce either inferior alveolar nerve block anesthesia (Trial 1) or maxillary infiltration anesthesia (Trial 2). In each trial, subjects received, in a randomized sequence, each of the three formulations to determine efficacy (success rate) and anesthetic characteristics (onset time and duration). The authors evaluated pulpal anesthesia via subjects' response to electric pulp testing (EPT). Results. A total of 126 subjects were enrolled in the two studies (63 subjects in each trial). In both mandibular and maxillary trials, the success rates for inducing profound anesthesia (EPT score ≥ 80), the mean onset times and the mean durations of anesthesia were similar for both epinephrine-containing formulations (A200 and A100). In subjects who received the formulation containing no epinephrine (Aw/o), the success rate for profound anesthesia was significantly less. Conclusion. These studies demonstrated that the inclusion of epinephrine in 4 percent articaine anesthetic formulations is essential for achieving profound anesthesia. The authors found that the A200 formulation provided a level of pulpal anesthesia comparable with that of the A100 formulation.

KW - Articaine

KW - Clinical trial

KW - Dentistry

KW - Epinephrine

KW - Local anesthesia

UR - http://www.scopus.com/inward/record.url?scp=33845283870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845283870&partnerID=8YFLogxK

U2 - 10.14219/jada.archive.2006.0093

DO - 10.14219/jada.archive.2006.0093

M3 - Article

C2 - 17082284

AN - SCOPUS:33845283870

VL - 137

SP - 1572

EP - 1581

JO - Journal of the American Dental Association

JF - Journal of the American Dental Association

SN - 0002-8177

IS - 11

ER -